| Christian F Schmutz, MD | |
|
1350 Baldy Ave Ste A, Pocatello, ID 83201-7104 | |
| (208) 346-7500 | |
| (208) 346-7501 |
| Full Name | Christian F Schmutz |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1350 Baldy Ave Ste A, Pocatello, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023645272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 12401847-1205 (Utah) | Primary |
| Entity Name | Pearl Health Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447426465 PECOS PAC ID: 0840356077 Enrollment ID: O20090312000617 |
News Archive
The Sudden Cardiac Arrest Foundation today announced the grand prize winner of its You Can Save a Life Video Awareness Contest. The student competition invited teams to submit videos about the impact of sudden cardiac arrest and the importance of CPR and automated external defibrillators, empowering students and communities to make a difference in helping to save lives.
In a recent bioRxiv preprint paper, researchers from the US and Italy utilized molecular dynamics simulations and revealed that the conformational stability of the SARS-CoV-2 binding site, bound inhibitors, and the hydrogen bond networks of the viral main protease (Mpro) are highly sensitive to protonation assignments.
Actuated Medical, Inc. and its TubeClear® system have been selected as one of three finalists for Pennsylvania Bio's 2013 Patient Impact Award. This award recognizes Life Sciences innovations in Pennsylvania that have made a significant contribution to the quality of health care or life of patients.
Aeterna Zentaris Inc. today announced that the Michael E. DeBakey Veterans Affairs Medical Center, in Houston, Texas, has initiated a Phase 2A trial assessing the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130 (macimorelin), in patients with cancer cachexia.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christian F Schmutz, MD 2705 E 17th St, Ammon, ID 83406-6601 Ph: (208) 346-7500 | Christian F Schmutz, MD 1350 Baldy Ave Ste A, Pocatello, ID 83201-7104 Ph: (208) 346-7500 |
News Archive
The Sudden Cardiac Arrest Foundation today announced the grand prize winner of its You Can Save a Life Video Awareness Contest. The student competition invited teams to submit videos about the impact of sudden cardiac arrest and the importance of CPR and automated external defibrillators, empowering students and communities to make a difference in helping to save lives.
In a recent bioRxiv preprint paper, researchers from the US and Italy utilized molecular dynamics simulations and revealed that the conformational stability of the SARS-CoV-2 binding site, bound inhibitors, and the hydrogen bond networks of the viral main protease (Mpro) are highly sensitive to protonation assignments.
Actuated Medical, Inc. and its TubeClear® system have been selected as one of three finalists for Pennsylvania Bio's 2013 Patient Impact Award. This award recognizes Life Sciences innovations in Pennsylvania that have made a significant contribution to the quality of health care or life of patients.
Aeterna Zentaris Inc. today announced that the Michael E. DeBakey Veterans Affairs Medical Center, in Houston, Texas, has initiated a Phase 2A trial assessing the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130 (macimorelin), in patients with cancer cachexia.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
› Verified 6 days ago
Dr. Robert Michael Kennedy, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 777 Hospital Way, G15, Pocatello, ID 83201 Phone: 208-239-2722 Fax: 208-239-3759 | |
Dr. Kathleen Anne Erwin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-2571 Fax: 208-239-3665 | |
Dr. Mary Elizabeth Gerard, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 333 N 18th Ave Ste B4, Pocatello, ID 83201 Phone: 208-232-2233 Fax: 208-232-2299 | |
Dr. William Hazle, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 500 S 11th Ave, Pocatello, ID 83201 Phone: 972-420-8345 Fax: 972-420-7770 | |
Richard D Karem, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-2722 Fax: 208-239-3759 | |
Scott S Petty, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1777 E Clark St, Suite 330, Pocatello, ID 83201 Phone: 208-233-1033 |